The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Resistance mechanisms to targeted therapies in ROS1+ and ALK+ non-small cell lung cancer.
 
Caroline Elizabeth McCoach
No Relationships to Disclose
 
Anh T. Le
Patents, Royalties, Other Intellectual Property - Abbott Molecular
 
Dara Aisner
Honoraria - AstraZeneca; Clovis Oncology
Consulting or Advisory Role - Casdin Capital; Oxford Oncology
 
Katherine Gowan
No Relationships to Disclose
 
Kenneth L Jones
No Relationships to Disclose
 
Dan Merrick
No Relationships to Disclose
 
Paul A. Bunn
Consulting or Advisory Role - AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Daiichi Sankyo; Lilly; Merck; Merck Serono; Novartis; Roche/Genentech
Research Funding - Eisai (Inst)
 
William T. Purcell
No Relationships to Disclose
 
Marileila Varella-Garcia
Research Funding - Abbott Molecular (Inst)
Patents, Royalties, Other Intellectual Property - Abbott Molecular (Inst)
 
D. Ross Camidge
No Relationships to Disclose
 
Robert Charles Doebele
Honoraria - AstraZeneca; Clovis Oncology; Loxo; OxOnc; Pfizer
Consulting or Advisory Role - Array BioPharma; Lilly; Loxo; OxOnc; Pfizer; Pfizer
Research Funding - Abbott Molecular; Loxo; Mirati Therapeutics
Patents, Royalties, Other Intellectual Property - Licensing Fees for Biologic Material from Ariad (Inst); Licensing Fees for Biologic Material from Blueprint Medicines (Inst); Licensing Fees for Biologic Material from Chugai (Inst); Licensing Fees for Biologic Materials from GVKbio; Licensing Fees for Biologic Materials from Loxo Oncology (Inst); Licensing Fees from Abbott Molecular for Patent PCT/US2013/057495